[Red-cell alloimmunization: prevention and management].

Q3 Medicine Tunisie Medicale Pub Date : 2009-04-01
Khaled Boudhraa, Sihem Mammou, Nadia Ben Salah, Med Faouzi Gara
{"title":"[Red-cell alloimmunization: prevention and management].","authors":"Khaled Boudhraa,&nbsp;Sihem Mammou,&nbsp;Nadia Ben Salah,&nbsp;Med Faouzi Gara","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Although very rare, red-cell immunization is a main factor of hemolytic fetal anemia and severe neonatal jaundice. We emphasize on the prevention of immunization in different situations of feto maternal bleeding by early intravenous injection of 200 at 300 IU or more depending on the term of pregnancy, the circumstances and results of the Kleihauer's test. Prophylaxis corresponds a systematic intramuscular injection of 300 IU immunoglobulin (Natead ) at 28 WA, is performed in many countries. This measure implies information and rigor from Perinatal's professional. If this systematic prophylaxis was conducted, it is not necessary to repeat the IAR until the birth. But if the patient has not received the injection of 28 WA, IAR of the 8th month must be maintained.</p>","PeriodicalId":38818,"journal":{"name":"Tunisie Medicale","volume":"87 4","pages":"240-5"},"PeriodicalIF":0.0000,"publicationDate":"2009-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tunisie Medicale","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Although very rare, red-cell immunization is a main factor of hemolytic fetal anemia and severe neonatal jaundice. We emphasize on the prevention of immunization in different situations of feto maternal bleeding by early intravenous injection of 200 at 300 IU or more depending on the term of pregnancy, the circumstances and results of the Kleihauer's test. Prophylaxis corresponds a systematic intramuscular injection of 300 IU immunoglobulin (Natead ) at 28 WA, is performed in many countries. This measure implies information and rigor from Perinatal's professional. If this systematic prophylaxis was conducted, it is not necessary to repeat the IAR until the birth. But if the patient has not received the injection of 28 WA, IAR of the 8th month must be maintained.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[红细胞异体免疫:预防和管理]。
虽然非常罕见,红细胞免疫是溶血性胎儿贫血和严重新生儿黄疸的主要因素。我们强调预防免疫接种在不同情况下的胎母出血,早期静脉注射200或300 IU或更多,根据妊娠期,情况和克莱豪尔试验的结果。在许多国家,预防相当于在28wa时系统地肌肉注射300 IU免疫球蛋白(Natead)。这项措施意味着来自围产期专业人员的信息和严格性。如果进行了这种系统预防,则没有必要在分娩前重复IAR。但如果患者未接受28wa注射,则必须维持第8个月的IAR。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Tunisie Medicale
Tunisie Medicale Medicine-Medicine (all)
CiteScore
1.00
自引率
0.00%
发文量
72
期刊最新文献
A ten-year hemovigilance report in the regional blood transfusion center of Sfax (Tunisia). Agenesis of the Dorsal Pancreas: An Uncommon Cause of Pancreatic Diabetes in Young Adults. A Case Report. Clinical, radiological and therapeutic features of exogenous lipoid pneumonia. Contribution of biological methods in the neonatal diagnosis of congenital toxoplasmosis in Tunisia. Predictors of thrombo-embolic events in Covid-19 Ambulatory Patients: Insights from the TUNACOV Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1